Enveric Biosciences, Inc. (ENVB)
1.42
+0.04
(+2.90%)
USD |
NASDAQ |
Oct 27, 16:00
1.44
+0.02
(+1.41%)
After-Hours: 20:00
Enveric Biosciences Price : 1.42 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 1.356 | 1.45 | 1.356 | 1.42 | 56492.00 |
| Oct 26, 2026 | 1.37 | 1.41 | 1.30 | 1.38 | 30580.00 |
| Oct 23, 2026 | 1.44 | 1.505 | 1.39 | 1.40 | 33348.00 |
| Oct 22, 2026 | 1.51 | 1.57 | 1.44 | 1.46 | 35130.00 |
| Oct 21, 2026 | 1.465 | 1.588 | 1.430 | 1.51 | 84519.00 |
| Oct 20, 2026 | 1.375 | 1.445 | 1.375 | 1.44 | 31409.00 |
| Oct 19, 2026 | 1.38 | 1.425 | 1.36 | 1.39 | 31544.00 |
| Oct 16, 2026 | 1.35 | 1.442 | 1.35 | 1.38 | 22527.00 |
| Oct 15, 2026 | 1.37 | 1.438 | 1.35 | 1.39 | 21205.00 |
| Oct 14, 2026 | 1.38 | 1.45 | 1.33 | 1.37 | 163912.0 |
| Oct 13, 2026 | 1.43 | 1.49 | 1.38 | 1.40 | 102068.0 |
| Oct 12, 2026 | 1.43 | 1.520 | 1.40 | 1.47 | 114677.0 |
| Oct 09, 2026 | 1.48 | 1.495 | 1.44 | 1.45 | 50246.00 |
| Oct 08, 2026 | 1.47 | 1.531 | 1.46 | 1.52 | 64867.00 |
| Oct 07, 2026 | 1.45 | 1.510 | 1.45 | 1.495 | 41370.00 |
| Oct 06, 2026 | 1.53 | 1.53 | 1.43 | 1.47 | 50964.00 |
| Oct 05, 2026 | 1.46 | 1.530 | 1.45 | 1.51 | 54328.00 |
| Oct 02, 2026 | 1.51 | 1.53 | 1.46 | 1.48 | 72978.00 |
| Oct 01, 2026 | 1.455 | 1.48 | 1.41 | 1.46 | 83632.00 |
| Sep 30, 2026 | 1.44 | 1.53 | 1.421 | 1.485 | 57070.00 |
| Sep 29, 2026 | 1.46 | 1.480 | 1.422 | 1.45 | 46474.00 |
| Sep 28, 2026 | 1.51 | 1.56 | 1.450 | 1.47 | 63605.00 |
| Sep 25, 2026 | 1.522 | 1.53 | 1.480 | 1.50 | 38233.00 |
| Sep 24, 2026 | 1.57 | 1.58 | 1.478 | 1.545 | 85017.00 |
| Sep 23, 2026 | 1.576 | 1.60 | 1.52 | 1.565 | 114948.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| LENZ Therapeutics, Inc. | 3.15 |
| Impact BioMedical, Inc. | 3.55 |
| ANI Pharmaceuticals, Inc. | 71.17 |
| Corcept Therapeutics, Inc. | 87.59 |
| Veru, Inc. | 2.28 |
Price Related Metrics
| Price to Book Value | 0.6915 |
| Earnings Yield | -1.16K% |
| Market Cap | 5.589M |